|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
7
|
Resverlogix Corp.
|
Mar 30, 2020 09:32AM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
1
|
Resverlogix Corp.
|
Mar 30, 2020 12:10PM
|
|
I asked IR today about why no aGFR data....
|
4
|
Resverlogix Corp.
|
Mar 30, 2020 09:49PM
|
|
Re: Big YouTube presentation on April 8, 2020
|
6
|
Resverlogix Corp.
|
Apr 10, 2020 10:50AM
|
|
Re: Big YouTube presentation on April 8, 2020
|
4
|
Resverlogix Corp.
|
Apr 10, 2020 11:19AM
|
|
Article on Epigenetics
|
2
|
Resverlogix Corp.
|
Apr 25, 2020 01:27AM
|
|
Got back from IR
|
3
|
Resverlogix Corp.
|
May 01, 2020 04:53PM
|
|
Re: June 21, 2018.
|
2
|
Resverlogix Corp.
|
Jun 09, 2020 12:41PM
|
|
Re: Still waiting for that BETonMACE CKD sub-study 7 months later
|
2
|
Resverlogix Corp.
|
Jun 12, 2020 09:35AM
|
|
Re: Recent rise in SP...
|
2
|
Resverlogix Corp.
|
Sep 28, 2020 12:16PM
|
|
Re: Rules of thumb and broken thumbs...
|
2
|
Resverlogix Corp.
|
Sep 29, 2020 12:12PM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
9
|
Resverlogix Corp.
|
Dec 22, 2020 08:06AM
|
